Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 1
2006 2
2007 2
2009 1
2010 2
2012 1
2013 2
2015 1
2016 3
2017 2
2018 1
2019 2
2020 2
2021 2
2022 5
2023 5
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy.
Mosna F, Borlenghi E, Litzow M, Byrd JC, Papayannidis C, Tecchio C, Ferrara F, Marcucci G, Cairoli R, Morgan EA, Gurrieri C, Yeung CCS, Deeg HJ, Capelli D, Candoni A, Gotlib JR, Lunghi M, Pullarkat S, Lanza F, Galimberti S, Forghieri F, Venditti A, Festuccia M, Audisio E, Marvalle D, Rigolin GM, Roti G, DiBona E, Visani G, Albano F, Eisfeld AK, Valent P, Huls G, Borthakur G, Krampera M, Martinelli G, Kröger N, Sperotto A, Gottardi M. Mosna F, et al. Among authors: gurrieri c. Haematologica. 2025 Mar 1;110(3):608-620. doi: 10.3324/haematol.2024.285448. Haematologica. 2025. PMID: 39385741 Free PMC article.
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.
Guolo F, Fianchi L, Martelli MP, Lussana F, Grimaldi F, Pilo F, Rondoni M, Filì C, Minetto P, Capelli D, Chiusolo P, Breccia M, Mastaglio S, Bernardi M, Bocchia M, Fumagalli M, Galimberti S, Mancini V, Piccioni AL, Maurillo L, Fracchiolla NS, Palmieri R, Vetro C, Papayannidis C, Brunetti L, Sperotto A, Gigli F, Zappasodi P, Mulé A, Patti C, Borlenghi E, Dargenio M, Lessi F, Cerrano M, Cilloni D, Isidori A, Lunghi M, Alati C, Gurrieri C, Riva C, Marconi G, Lotesoriere I, Gatani S, Scattolin AM, Caizzi M, Perrone S, Billio A, Gherlinzoni F, Mannelli F, Gottardi M, Cairoli R, Candoni A, Ferrara F, Pagano L, Lemoli RM, Venditti A, Todisco E. Guolo F, et al. Among authors: gurrieri c. Am J Hematol. 2025 Dec;100(12):2293-2304. doi: 10.1002/ajh.70083. Epub 2025 Sep 24. Am J Hematol. 2025. PMID: 40990091 Free PMC article.
CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis.
Quotti Tubi L, Canovas Nunes S, Mandato E, Pizzi M, Vitulo N, D'Agnolo M, Colombatti R, Martella M, Boaro MP, Doriguzzi Breatta E, Fregnani A, Spinello Z, Nabergoj M, Filhol O, Boldyreff B, Albiero M, Fadini GP, Gurrieri C, Vianello F, Semenzato G, Manni S, Trentin L, Piazza F. Quotti Tubi L, et al. Among authors: gurrieri c. Hemasphere. 2023 Nov 23;7(12):e978. doi: 10.1097/HS9.0000000000000978. eCollection 2023 Dec. Hemasphere. 2023. PMID: 38026791 Free PMC article.
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.
Battaglia G, Lazzarotto D, Tanasi I, Gurrieri C, Forlani L, Mauro E, Capraro F, Ciotti G, De Bellis E, Callegari C, Tosoni L, Fanin M, Morelli GL, Simio C, Skert C, Gottardi M, Zaja F, Toffoletti E, Damiani D, Fanin R, Tiribelli M. Battaglia G, et al. Among authors: gurrieri c. J Clin Med. 2025 Jan 22;14(3):700. doi: 10.3390/jcm14030700. J Clin Med. 2025. PMID: 39941372 Free PMC article.
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Angotzi F, Petrella M, Berno T, Binotto G, Bonetto G, Branca A, Carraro M, Cavaretta CA, Cellini A, D'Amore F, Forlani L, Gianesello I, Gurrieri C, Imbergamo S, Lessi F, Maroccia A, Mazzetto F, Pavan L, Pezone S, Piazza F, Pravato S, Ruocco V, Scapinello G, Vianello F, Zambello R, Zatta I, Zoletto S, Padoan A, Trentin L, Visentin A. Angotzi F, et al. Among authors: gurrieri c. Front Oncol. 2023 Jun 22;13:1212752. doi: 10.3389/fonc.2023.1212752. eCollection 2023. Front Oncol. 2023. PMID: 37427126 Free PMC article.
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital.
Danesin N, Lo Schirico M, Scapinello G, Grassi A, Riva M, Berno T, Branca A, Visentin A, Carraro M, Pavan L, Manni S, Bonaldi L, Martines A, Bertorelle R, Vianello F, Gurrieri C, Briani C, Zambello R, Trentin L, Piazza F. Danesin N, et al. Among authors: gurrieri c. Hemasphere. 2023 Oct 3;7(10):e964. doi: 10.1097/HS9.0000000000000964. eCollection 2023 Oct. Hemasphere. 2023. PMID: 37799344 Free PMC article. No abstract available.
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Cerrano M, Bonifacio M, Olivi M, Curti A, Malagola M, Dargenio M, Scattolin AM, Papayannidis C, Forghieri F, Gurrieri C, Tanasi I, Zappasodi P, La Starza R, Fracchiolla NS, Chiusolo P, Giaccone L, Del Principe MI, Giglio F, Defina M, Favre C, Rizzari C, Castella B, Pizzolo G, Ferrara F, Chiaretti S, Foà R. Cerrano M, et al. Among authors: gurrieri c. Haematologica. 2022 Apr 1;107(4):996-999. doi: 10.3324/haematol.2021.279851. Haematologica. 2022. PMID: 35021604 Free PMC article. No abstract available.
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma.
Fregnani A, Saggin L, Gianesin K, Quotti Tubi L, Carraro M, Barilà G, Scapinello G, Bonetto G, Pesavento M, Berno T, Branca A, Gurrieri C, Zambello R, Semenzato G, Trentin L, Manni S, Piazza F. Fregnani A, et al. Among authors: gurrieri c. Cancers (Basel). 2022 Aug 29;14(17):4173. doi: 10.3390/cancers14174173. Cancers (Basel). 2022. PMID: 36077711 Free PMC article.
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation.
Zambello R, Bonaldi L, Berno T, Martines A, Sechettin E, De March E, Branca A, Lico A, Minotto C, Briani C, Gurrieri C, Temporin F, Battistutta C, Piazza F, Cavraro M, Trentin L, Semenzato G. Zambello R, et al. Among authors: gurrieri c. Clin Lymphoma Myeloma Leuk. 2015 Oct;15(10):592-8. doi: 10.1016/j.clml.2015.05.003. Epub 2015 Jun 6. Clin Lymphoma Myeloma Leuk. 2015. PMID: 26141212
39 results